Neuralink, the neurotechnology company co-founded by Tesla ( NASDAQ: TSLA) CEO Elon Musk, has joined a clinical trial aimed ...

Conagra's Q4 results and '26 guidance disappointed, yet valuation offers optimism. Explore potential growth via asset sales ...

Discover why giving up on dividend investing could be a costly mistake & explore top dividend investments to buy now for ...

Bank of America’s preferreds offer strong income security and attractive yields, with low redemption risk and solid coverage.

Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral ...

Cal-Maine Foods thrives with zero debt and diversification efforts. Discover its long-term potential despite egg price ...

Discover how OpenAI alumni are revolutionizing AI! Insights into Thinking Machines Lab & Anthropic, their funding milestones, ...

In two years, BrightSpire Capital (BRSP) will be growing its dividend and seeing strong performance. Read the full analysis ...

Venu Holding faces worsening losses and a complex capital structure that clouds shareholder value despite growth plans. Learn ...

The decline echoes a similar pattern in Q2 2022, which saw the Tech Demand Indicator score drop 12% following the first in a ...

City Office REIT’s shares trade near acquisition values, leaving minimal upside as deal risks outweigh remaining arbitrage.

Solesence shows strong growth and profitability with solid management alignment, but valuation reflects aggressive ...